Clinical Trials on Invasive Lobular Carcinoma
Total 27473 results
-
Laura EssermanMerck Sharp & Dohme LLC; ModernaTX, Inc.RecruitingCarcinoma, Intraductal, NoninfiltratingUnited States
-
University Medical Center GroningenCompletedCritically Ill | Suspected Invasive CandidiasisNetherlands
-
Medical University of GrazMedical University InnsbruckCompletedInvasive CandidiasisAustria
-
Fadoi Foundation, ItalyTerminated
-
Kevin WattCompletedInvasive CandidiasisUnited States
-
Duke UniversityPfizerCompleted
-
Henan Cancer HospitalRecruitingIntraoperative Complications | Perfusion; Complications | High-Risk, Non-Muscle Invasive Bladder Urothelial CarcinomaChina
-
Marwa Mahmoud HassanQena Oncology CenterEnrolling by invitationInvasive Breast CancerEgypt
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
University of WarwickPublic Health EnglandEnrolling by invitationBreast Cancer | Ductal Carcinoma in SituUnited Kingdom
-
Masonic Cancer Center, University of MinnesotaTerminatedBreast CancerUnited States
-
University of California, San FranciscoNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Centre Antoine LacassagneCompleted
-
Institute of Cancer Research, United KingdomUnknown
-
UroGen Pharma Ltd.Active, not recruitingBladder Cancer | Urothelial Carcinoma Bladder | Urothelial CarcinomaUnited States, Spain, Lithuania, Georgia, Bulgaria, Estonia, Latvia, Poland, Serbia, Austria
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingInvasive Breast Carcinoma | Early-Stage Breast Carcinoma | Stage I Breast Cancer AJCC v7 | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Ductal Breast Carcinoma... and other conditionsUnited States
-
University Hospital OstravaUniversity Hospital, MotolRecruiting
-
Yung Shin Pharm. Ind. Co., Ltd.Completed
-
Duke UniversityChildren's Hospital of PhiladelphiaCompletedInvasive CandidiasisUnited States, Saudi Arabia, Greece, Spain
-
Merck Sharp & Dohme LLCTerminated
-
Hasan Al-DorziKing Fahad Medical CityCompleted
-
PfizerVicuron PharmaceuticalsCompleted
-
University Hospital, RouenFederation Francophone de Cancerologie Digestive; UNICANCER; Federation of Research... and other collaboratorsUnknownResectable Pancreatic Duct AdenocarcinomaFrance
-
Ontario Clinical Oncology Group (OCOG)Recruiting
-
Alliance Foundation Trials, LLC.Patient-Centered Outcomes Research Institute; M.D. Anderson Cancer Center; Washington... and other collaboratorsActive, not recruitingDuctal Carcinoma in Situ | DCISUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Hologic, Inc.University of Southern CaliforniaCompleted
-
Yale UniversityPatient-Centered Outcomes Research InstituteCompletedDuctal Carcinoma In SituUnited States
-
Sunnybrook Health Sciences CentreTerminated
-
Windy Hill Medical, Inc.UnknownDuctal Carcinoma In SituUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingLiver and Intrahepatic Bile Duct CarcinomaUnited States
-
NSABP Foundation IncNational Cancer Institute (NCI); Southwest Oncology Group; North Central Cancer... and other collaboratorsCompletedBreast CancerUnited States, Canada, Puerto Rico
-
Fudan UniversityUnknown
-
Robert Krause, MDCompletedInvasive Candidiasis | Pulmonary CandidiasisAustria
-
UroGen Pharma Ltd.CompletedBladder Cancer | Urothelial Carcinoma Bladder | Urothelial CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Texas Appropriation for Rare and Aggressive...RecruitingInvasive Breast Carcinoma | Inflammatory Breast Carcinoma | Second Primary Malignant NeoplasmUnited States
-
Varian, a Siemens Healthineers CompanyRigshospitalet, Denmark; Herlev HospitalRecruitingMuscle-Invasive Bladder CarcinomaDenmark
-
ElyptaLund UniversityRecruitingMuscle-Invasive Bladder CarcinomaSweden, Denmark, Italy
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Third Affiliated Hospital...Not yet recruitingMuscle-Invasive Bladder Carcinoma
-
IRCCS San RaffaeleBristol-Myers SquibbRecruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingInvasive Breast Carcinoma | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor PositiveUnited States
-
C2i GenomicsFox Chase Cancer Center; Baylor College of Medicine; New York University; The Cleveland... and other collaboratorsTerminated
-
Hospital Universitario La FeCompletedFungal Invasive DiseaseSpain
-
Astellas Pharma IncCompletedMycosesBelgium, Germany, Spain, France, Italy, Turkey, Austria, Switzerland, Hungary, United Kingdom, Israel, Denmark, Greece, Finland, Romania
-
UroGen Pharma Ltd.Not yet recruitingBladder Cancer | Urothelial Carcinoma Bladder | Urothelial Carcinoma
-
UroGen Pharma Ltd.RecruitingBladder Cancer | Non-muscle Invasive Bladder Cancer | Urothelial Carcinoma Bladder | NMIBC | Urothelial Carcinoma Recurrent | Carcinoma in Situ of BladderUnited States, Italy, Spain
-
PharmalinkActive, not recruitingNon-muscle-invasive Bladder CancerSpain
-
Institut Cancerologie de l'OuestRecruitingMastectomy | Ductal Carcinoma in Situ | Extensive DiseaseFrance
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingInvasive Breast Carcinoma | Stage I Breast Cancer AJCC v7 | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Breast Adenocarcinoma | Ductal Breast Carcinoma In Situ and other conditionsUnited States